Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Maxamine inhibits sarcomas in preclinical study

Oct. 19, 2000

Roche begins E.U. launch for Herceptin

Oct. 11, 2000

Two dendritic/cancer cell fusion trials begun by Genzyme Molecular Oncology

Oct. 9, 2000

InterMune to commence Actimmune clinical trial in ovarian cancer

Oct. 4, 2000

FDA completes review of supplemental BLA for Rituxan

Oct. 2, 2000

O-Vax ovarian cancer vaccine awarded orphan drug status in U.S.

Sep. 29, 2000

Corixa to file Melacine BLA for stage II melanoma

Sep. 29, 2000

Immunomedics commences phase III clinical trial with LymphoCide

Sep. 28, 2000

Vical reports interim data from phase II trial of Leuvectin

Sep. 26, 2000

ImmunoGen/SmithKline Beecham open second trial of cancer treatment

Sep. 26, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...